The mPVN mediates blockade of NPY-induced feeding by a Y5 receptor antagonist: a c-FOS analysis
- PMID: 11287108
- DOI: 10.1016/s0196-9781(01)00360-6
The mPVN mediates blockade of NPY-induced feeding by a Y5 receptor antagonist: a c-FOS analysis
Abstract
To identify the site(s) of NPY Y5 receptor (Y5R) mediation of NPY-induced feeding, we employed c-Fos immunostaining and a selective Y5R antagonist (Y5R-A), CGP71683A, in adult male rats. Intracerebroventricular (icv) administration of NPY stimulated feeding and c-Fos-like immunoreactivity (FLI) in the dorsomedial hypothalamus, supraoptic nucleus and the two subdivision of the hypothalamic paraventricular nucleus (pPVN), the parvocellular (pPVN), and magnocellular (mPVN). Y5R-A on its own, injected either intraperitoneally or icv, neither affected feeding nor FLI in hypothalamic sites. However, Y5R-A pretreatment suppressed NPY-induced food intake and FLI selectively in the mPVN. Taken together with our previous similar finding of Y1R involvement, these results suggest that NPY receptor sites concerned with feeding behavior reside selectively in the mPVN and Y1 and Y5 receptors are either coexpressed or expressed separately in those target neurons that promote appetitive drive.
Similar articles
-
Inhibition of neuropeptide Y (NPY)-induced feeding and c-Fos response in magnocellular paraventricular nucleus by a NPY receptor antagonist: a site of NPY action.Endocrinology. 1999 Oct;140(10):4494-500. doi: 10.1210/endo.140.10.7058. Endocrinology. 1999. PMID: 10499503
-
Neural substrates for leptin and neuropeptide Y (NPY) interaction: hypothalamic sites associated with inhibition of NPY-induced food intake.Physiol Behav. 1998 Jun 1;64(3):331-8. doi: 10.1016/s0031-9384(98)00065-1. Physiol Behav. 1998. PMID: 9748101
-
Neuropeptide Y Y5 receptor promotes cell growth through extracellular signal-regulated kinase signaling and cyclic AMP inhibition in a human breast cancer cell line.Mol Cancer Res. 2010 Apr;8(4):604-14. doi: 10.1158/1541-7786.MCR-09-0301. Epub 2010 Mar 23. Mol Cancer Res. 2010. PMID: 20332211
-
NPY and cohorts in regulating appetite, obesity and metabolic syndrome: beneficial effects of gene therapy.Neuropeptides. 2004 Aug;38(4):201-11. doi: 10.1016/j.npep.2004.06.003. Neuropeptides. 2004. PMID: 15337372 Review.
-
Neuropeptide Y Y2 and Y5 receptors as potential targets for neuroprotective and antidepressant therapies: Evidence from preclinical studies.Prog Neuropsychopharmacol Biol Psychiatry. 2021 Dec 20;111:110349. doi: 10.1016/j.pnpbp.2021.110349. Epub 2021 May 13. Prog Neuropsychopharmacol Biol Psychiatry. 2021. PMID: 33991587 Review.
Cited by
-
Circumventing leptin resistance for weight control.Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4279-81. doi: 10.1073/pnas.091101498. Proc Natl Acad Sci U S A. 2001. PMID: 11296275 Free PMC article. No abstract available.
-
Neuropeptide Y in normal eating and in genetic and dietary-induced obesity.Philos Trans R Soc Lond B Biol Sci. 2006 Jul 29;361(1471):1159-85. doi: 10.1098/rstb.2006.1855. Philos Trans R Soc Lond B Biol Sci. 2006. PMID: 16874931 Free PMC article. Review.
-
Feeding behavior and gene expression of appetite-related neuropeptides in mice lacking for neuropeptide Y Y5 receptor subclass.World J Gastroenterol. 2008 Nov 7;14(41):6312-7. doi: 10.3748/wjg.14.6312. World J Gastroenterol. 2008. PMID: 19009645 Free PMC article.
-
An Indirect Action Contributes to C-Fos Induction in Paraventricular Hypothalamic Nucleus by Neuropeptide Y.Sci Rep. 2016 Jan 27;6:19980. doi: 10.1038/srep19980. Sci Rep. 2016. PMID: 26813148 Free PMC article.
-
Hypothalamic regulatory pathways and potential obesity treatment targets.Endocrine. 2006 Feb;29(1):33-48. doi: 10.1385/endo:29:1:33. Endocrine. 2006. PMID: 16622291 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous